The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Understanding the rate of erectile dysfunction (ED) and testosterone deficiency is crucial in developing screening and treatment strategies.

Exposure to extreme heat stress is associated with increased risks for emergency department visits and unplanned hospital ...

For patients undergoing breast reconstruction after mastectomy, age impacts surgical outcomes, with older age negatively ...

Vaccination is one of the most effective ways to protect children against influenza and its complications, including severe ...

The health sector's share of the economy was 17.6 percent in 2023, which was similar to 17.4 percent in 2022, but lower than the share in 2020 and 2021 during the height of the pandemic.

Compared with women with normotensive pregnancies, women with gestational hypertension, preeclampsia, and eclampsia had 27%, 32%, and 70% increased risks for a new-onset neurological disorder ...

Targeted interventions aimed at older individuals with multiple cardiometabolic comorbidities may help mitigate their risk for kidney function decline. (HealthDay News) — Multimorbidity is ...

The investigators defined hyponatremia as a serum sodium level less than 135 mEq/L, and mild, moderate, and severe ...

The FDA has approved the first generic liraglutide indicated to improve glycemic control in adults and pediatric patients ...